University Of Luebeck
Clinical trials sponsored by University Of Luebeck, explained in plain language.
-
New heart ablation method aims to stop AFib recurrence
Disease control Not yet recruitingThis study tests whether a new catheter ablation system using pulsed field energy can better control persistent atrial fibrillation (AF) by targeting low-voltage areas in the heart and isolating the superior vena cava, in addition to standard pulmonary vein isolation. About 618 a…
Phase: NA • Sponsor: University of Luebeck • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a diabetes drug boost heart ablation success?
Disease control Not yet recruitingThis study tests whether taking semaglutide (a drug used for diabetes and weight loss) before a standard heart procedure called catheter ablation can help prevent atrial fibrillation from coming back. The trial will include 240 adults with obesity and symptomatic atrial fibrillat…
Phase: PHASE4 • Sponsor: University of Luebeck • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New study aims to decode biomarkers in common heart rhythm problems
Knowledge-focused Not yet recruitingThis study will measure various biomarkers in 200 people with certain heart rhythm problems (ventricular tachycardia, premature ventricular contractions, and AVNRT) who are scheduled for a catheter ablation procedure. The goal is to see if these biomarkers are linked to the speci…
Sponsor: University of Luebeck • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC